| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Comprehensive Analysis of Programmed Cell Death Ligand-1 Expression With the Clone SP142 Antibody in Non–Small-Cell Lung Cancer Patients
|
Takada, Kazuki
|
|
2017
|
18 |
5 |
p. 572-582.e1
5249 p.
|
artikel
|
| 2 |
An Open-Label, Randomized, Controlled Phase II Study of Paclitaxel-Carboplatin Chemotherapy With Necitumumab Versus Paclitaxel-Carboplatin Alone in First-Line Treatment of Patients With Stage IV Squamous Non–Small-Cell Lung Cancer
|
Spigel, David R.
|
|
2017
|
18 |
5 |
p. 480-488
9 p.
|
artikel
|
| 3 |
Assessment of the External Validity of the National Comprehensive Cancer Network and European Society for Medical Oncology Guidelines for Non–Small-Cell Lung Cancer in a Population of Patients Aged 80 Years and Older
|
Battisti, Nicolò Matteo Luca
|
|
2017
|
18 |
5 |
p. 460-471
12 p.
|
artikel
|
| 4 |
Association Between Environmental Tobacco Smoke Exposure and the Occurrence of EGFR Mutations and ALK Rearrangements in Never-smokers With Non–Small-cell Lung Cancer: Analyses From a Prospective Multinational ETS Registry
|
Soo, Ross A.
|
|
2017
|
18 |
5 |
p. 535-542
8 p.
|
artikel
|
| 5 |
Clinical Determinants of Durable Clinical Benefit of Pembrolizumab in Veterans With Advanced Non–Small-Cell Lung Cancer
|
Qin, Angel
|
|
2017
|
18 |
5 |
p. 559-564
6 p.
|
artikel
|
| 6 |
Comparative Analysis for Diagnostic Yield of Small Cell Lung Cancer by Cytology and Histology During the Same Bronchoscopic Procedure
|
Li, Wei-Nan
|
|
2017
|
18 |
5 |
p. e357-e361
nvt p.
|
artikel
|
| 7 |
Comparison of Clinically Relevant Mutation Profiles Between Preoperative Biopsy and Corresponding Surgically Resected Specimens in Japanese Patients With Non–Small-cell Lung Cancer by Amplicon-based Massively Parallel Sequencing
|
Isaka, Mitsuhiro
|
|
2017
|
18 |
5 |
p. 519-526.e1
4742 p.
|
artikel
|
| 8 |
Disparities in the Management of Patients With Stage I Small Cell Lung Carcinoma (SCLC): A Surveillance, Epidemiology and End Results (SEER) Analysis
|
Ahmed, Zaheer
|
|
2017
|
18 |
5 |
p. e315-e325
nvt p.
|
artikel
|
| 9 |
Early Results of Lung Cancer Screening and Radiation Dose Assessment by Low-dose CT at a Community Hospital
|
Jacobs, Corbin D.
|
|
2017
|
18 |
5 |
p. e327-e331
nvt p.
|
artikel
|
| 10 |
EBUS-TBNA as a Promising Method for the Evaluation of Tumor PD-L1 Expression in Lung Cancer
|
Sakakibara, Rie
|
|
2017
|
18 |
5 |
p. 527-534.e1
4814 p.
|
artikel
|
| 11 |
Editorial Board
|
|
|
2017
|
18 |
5 |
p. A1-
1 p.
|
artikel
|
| 12 |
Emotional Problems, Quality of Life, and Symptom Burden in Patients With Lung Cancer
|
Morrison, Eleshia J.
|
|
2017
|
18 |
5 |
p. 497-503
7 p.
|
artikel
|
| 13 |
Enrollment of Elderly Patients With Locally Advanced Non–Small Cell Lung Cancer in Multi-institutional Trials of Proton Beam Radiation Therapy
|
Verma, Vivek
|
|
2017
|
18 |
5 |
p. 441-443
3 p.
|
artikel
|
| 14 |
High Frequency of Programmed Death-ligand 1 Expression in Emphysematous Bullae-associated Lung Adenocarcinomas
|
Toyokawa, Gouji
|
|
2017
|
18 |
5 |
p. 504-511.e1
4607 p.
|
artikel
|
| 15 |
Immune Checkpoint Inhibitors for Patients With Advanced Non–Small-Cell Lung Cancer: A Systematic Review
|
Ellis, Peter M.
|
|
2017
|
18 |
5 |
p. 444-459.e1
4147 p.
|
artikel
|
| 16 |
Interstitial Lung Disease Associated With Crizotinib in Patients With Advanced Non–Small Cell Lung Cancer: Independent Review of Four PROFILE Trials
|
Yoneda, Ken Y.
|
|
2017
|
18 |
5 |
p. 472-479
8 p.
|
artikel
|
| 17 |
Long-term Outcomes of Induction Carboplatin and Gemcitabine Followed by Concurrent Radiotherapy With Low-dose Paclitaxel and Gemcitabine for Stage III Non–small-cell Lung Cancer
|
Guilbault, Catherine
|
|
2017
|
18 |
5 |
p. 565-571
7 p.
|
artikel
|
| 18 |
LUME-Meso: Design and Rationale of the Phase III Part of a Placebo-Controlled Study of Nintedanib and Pemetrexed/Cisplatin Followed by Maintenance Nintedanib in Patients With Unresectable Malignant Pleural Mesothelioma
|
Scagliotti, Giorgio V.
|
|
2017
|
18 |
5 |
p. 589-593
5 p.
|
artikel
|
| 19 |
Molecular Testing Turnaround Time for Non–Small Cell Lung Cancer in Routine Clinical Practice Confirms Feasibility of CAP/IASLC/AMP Guideline Recommendations: A Single-center Analysis
|
DiStasio, Marcello
|
|
2017
|
18 |
5 |
p. e349-e356
nvt p.
|
artikel
|
| 20 |
Nivolumab in Second-Line Treatment for Advanced Non–Small-Cell Lung Cancer With Squamous-Cell Histology: A Perspective Based on Pharmacologic Costs
|
Giuliani, Jacopo
|
|
2017
|
18 |
5 |
p. e363-e365
nvt p.
|
artikel
|
| 21 |
Non–Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
|
Wu, Geena X.
|
|
2017
|
18 |
5 |
p. 543-550.e3
549458 p.
|
artikel
|
| 22 |
Relationship Between Tumor Location and Outcome in Patients With Early-Stage Lung Cancer
|
Dahele, Max
|
|
2017
|
18 |
5 |
p. e367-e368
nvt p.
|
artikel
|
| 23 |
Safety Analyses of Pemetrexed-cisplatin and Pemetrexed Maintenance Therapies in Patients With Advanced Non-squamous NSCLC: Retrospective Analyses From 2 Phase III Studies
|
Langer, Corey J.
|
|
2017
|
18 |
5 |
p. 489-496
8 p.
|
artikel
|
| 24 |
Sensitivity of Cytology Specimens From Bronchial Aspirate or Washing During Bronchoscopy in the Diagnosis of Lung Malignancies: An Update
|
Girard, Philippe
|
|
2017
|
18 |
5 |
p. 512-518
7 p.
|
artikel
|
| 25 |
Stereotactic Body Radiotherapy for Early-stage Non–small-cell Lung Cancer in Patients 80 Years and Older: A Multi-center Analysis
|
Cassidy, Richard J.
|
|
2017
|
18 |
5 |
p. 551-558.e6
5.5799945E8 p.
|
artikel
|
| 26 |
Table of Contents
|
|
|
2017
|
18 |
5 |
p. A3-A7
nvt p.
|
artikel
|
| 27 |
The APPLE Trial: Feasibility and Activity of AZD9291 (Osimertinib) Treatment on Positive PLasma T790M in EGFR-mutant NSCLC Patients. EORTC 1613
|
Remon, Jordi
|
|
2017
|
18 |
5 |
p. 583-588
6 p.
|
artikel
|
| 28 |
Therapeutic Efficacy Comparison of 5 Major EGFR-TKIs in Advanced EGFR-positive Non–Small-cell Lung Cancer: A Network Meta-analysis Based on Head-to-Head Trials
|
Zhang, Yaxiong
|
|
2017
|
18 |
5 |
p. e333-e340
nvt p.
|
artikel
|
| 29 |
Treatment Patterns and Differences in Survival of Non-Small Cell Lung Cancer Patients Between Academic and Non-Academic Hospitals in the Netherlands
|
van der Linden, Naomi
|
|
2017
|
18 |
5 |
p. e341-e347
nvt p.
|
artikel
|
Tijdschrift beschrijving